ABSTRACT
BACKGROUND: COPD is a major cause of morbidity and mortality in populations eligible for lung cancer screening. We investigated the role of spirometry in a community-based lung cancer screening programme. METHODS: Ever smokers, age 55-74, resident in three deprived areas of Manchester were invited to a 'Lung Health Check' (LHC) based in convenient community locations. Spirometry was incorporated into the LHCs alongside lung cancer risk estimation (Prostate, Lung, Colorectal and Ovarian Study Risk Prediction Model, 2012 version (PLCOM2012)), symptom assessment and smoking cessation advice. Those at high risk of lung cancer (PLCOM2012 ≥1.51%) were eligible for annual low-dose CT screening over two screening rounds. Airflow obstruction was defined as FEV1/FVC<0.7. Primary care databases were searched for any prior diagnosis of COPD. RESULTS: 99.4% (n=2525) of LHC attendees successfully performed spirometry; mean age was 64.1±5.5, 51% were women, 35% were current smokers. 37.4% (n=944) had airflow obstruction of which 49.7% (n=469) had no previous diagnosis of COPD. 53.3% of those without a prior diagnosis were symptomatic (n=250/469). After multivariate analysis, the detection of airflow obstruction without a prior COPD diagnosis was associated with male sex (adjOR 1.84, 95% CI 1.37 to 2.47; p<0.0001), younger age (p=0.015), lower smoking duration (p<0.0001), fewer cigarettes per day (p=0.035), higher FEV1/FVC ratio (<0.0001) and being asymptomatic (adjOR 4.19, 95% CI 2.95 to 5.95; p<0.0001). The likelihood of screen detected lung cancer was significantly greater in those with evidence of airflow obstruction who had a previous diagnosis of COPD (adjOR 2.80, 95% CI 1.60 to 8.42; p=0.002). CONCLUSIONS: Incorporating spirometry into a community-based targeted lung cancer screening programme is feasible and identifies a significant number of individuals with airflow obstruction who do not have a prior diagnosis of COPD.
Subject(s)
Airway Obstruction/epidemiology , Lung Neoplasms/complications , Lung Neoplasms/diagnosis , Pulmonary Disease, Chronic Obstructive/complications , Spirometry , Aged , Early Detection of Cancer , Feasibility Studies , Female , Humans , Male , Middle Aged , Prevalence , Smoking , United KingdomABSTRACT
INTRODUCTION: Low-dose CT (LDCT) screening of high-risk smokers reduces lung cancer (LC) specific mortality. Determining screening eligibility using individualised risk may improve screening effectiveness and reduce harm. Here, we compare the performance of two risk prediction models (PLCOM2012 and Liverpool Lung Project model (LLPv2)) and National Lung Screening Trial (NLST) eligibility criteria in a community-based screening programme. METHODS: Ever-smokers aged 55-74, from deprived areas of Manchester, were invited to a Lung Health Check (LHC). Individuals at higher risk (PLCOM2012 score ≥1.51%) were offered annual LDCT screening over two rounds. LLPv2 score was calculated but not used for screening selection; ≥2.5% and ≥5% thresholds were used for analysis. RESULTS: PLCOM2012 ≥1.51% selected 56% (n=1429) of LHC attendees for screening. LLPv2 ≥2.5% also selected 56% (n=1430) whereas NLST (47%, n=1188) and LLPv2 ≥5% (33%, n=826) selected fewer. Over two screening rounds 62 individuals were diagnosed with LC; representing 87% (n=62/71) of 6-year incidence predicted by mean PLCOM2012 score (5.0%). 26% (n=16/62) of individuals with LC were not eligible for screening using LLPv2 ≥5%, 18% (n=11/62) with NLST criteria and 7% (n=5/62) with LLPv2 ≥2.5%. NLST eligible Manchester attendees had 2.5 times the LC detection rate than NLST participants after two annual screens (≈4.3% (n=51/1188) vs 1.7% (n=438/26 309); p<0.0001). Adverse measures of health, including airflow obstruction, respiratory symptoms and cardiovascular disease, were positively correlated with LC risk. Coronary artery calcification was predictive of LC (adjOR 2.50, 95% CI 1.11 to 5.64; p=0.028). CONCLUSION: Prospective comparisons of risk prediction tools are required to optimise screening selection in different settings. The PLCOM2012 model may underestimate risk in deprived UK populations; further research focused on model calibration is required.
Subject(s)
Early Detection of Cancer , Lung Neoplasms/diagnosis , Lung Neoplasms/etiology , Patient Selection , Aged , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Risk Assessment , Smoking , Tomography, X-Ray Computed , United KingdomABSTRACT
We report baseline results of a community-based, targeted, low-dose CT (LDCT) lung cancer screening pilot in deprived areas of Manchester. Ever smokers, aged 55-74 years, were invited to 'lung health checks' (LHCs) next to local shopping centres, with immediate access to LDCT for those at high risk (6-year risk ≥1.51%, PLCOM2012 calculator). 75% of attendees (n=1893/2541) were ranked in the lowest deprivation quintile; 56% were high risk and of 1384 individuals screened, 3% (95% CI 2.3% to 4.1%) had lung cancer (80% early stage) of whom 65% had surgical resection. Taking lung cancer screening into communities, with an LHC approach, is effective and engages populations in deprived areas.
Subject(s)
Community Health Services/organization & administration , Early Detection of Cancer/methods , Lung Neoplasms/diagnostic imaging , Poverty Areas , Aged , Community Health Services/methods , England/epidemiology , Female , Health Services Accessibility , Humans , Lung Neoplasms/epidemiology , Lung Neoplasms/etiology , Male , Mass Screening/methods , Middle Aged , Mobile Health Units , Pilot Projects , Prevalence , Smoking/adverse effects , Tomography, X-Ray ComputedABSTRACT
We report results from the second annual screening round (T1) of Manchester's 'Lung Health Check' pilot of community-based lung cancer screening in deprived areas (undertaken June to August 2017). Screening adherence was 90% (n=1194/1323): 92% of CT scans were classified negative, 6% indeterminate and 2.5% positive; there were no interval cancers. Lung cancer incidence was 1.6% (n=19), 79% stage I, treatments included surgery (42%, n=9), stereotactic ablative radiotherapy (26%, n=5) and radical radiotherapy (5%, n=1). False-positive rate was 34.5% (n=10/29), representing 0.8% of T1 participants (n=10/1194). Targeted community-based lung cancer screening promotes high screening adherence and detects high rates of early stage lung cancer.
Subject(s)
Early Detection of Cancer/methods , Lung Neoplasms/diagnosis , Mass Screening/methods , Public Health , Smoking/adverse effects , Tomography, X-Ray Computed/methods , Aged , Female , Humans , Incidence , Lung Neoplasms/epidemiology , Male , Middle Aged , Pilot Projects , Smoking/epidemiology , United Kingdom/epidemiologyABSTRACT
OBJECTIVE Lung transplantation is an established treatment for end-stage pulmonary disease. Complications of lung transplantation include airway stenosis and dehiscence, reimplantation response, acute rejection, infection, posttransplantation lymphoproliferative disorder, and bronchiolitis obliterans syndrome. The incidence of graft rejection and airway anastomosis experienced in the early years of lung transplantation have been significantly reduced by advances in immunosuppression and surgical techniques. Infection is currently the most common cause of mortality during the first 6 months after transplantation, whereas chronic rejection or obliterative bronchiolitis is the most common cause of mortality thereafter. This article reviews the radiologic findings of different surgical techniques as well as the common early and late complications of lung transplantation. CONCLUSION Radiology plays a pivotal role in the diagnosis and management of complications of lung transplantation. Advancements in surgical technique and medical therapy influence the spectrum of expected radiologic findings. Familiarity with the radiologic appearances of common surgical techniques and complications of lung transplantation is important.
Subject(s)
Lung Transplantation/adverse effects , Lung Transplantation/diagnostic imaging , Adult , Bacterial Infections/diagnostic imaging , Bacterial Infections/etiology , Biopsy/adverse effects , Bronchi/pathology , Bronchial Diseases/diagnostic imaging , Bronchial Diseases/etiology , Bronchial Diseases/pathology , Bronchiolitis Obliterans/diagnostic imaging , Bronchiolitis Obliterans/etiology , Female , Graft Rejection/diagnostic imaging , Humans , Hydropneumothorax/diagnostic imaging , Hydropneumothorax/etiology , Lung/diagnostic imaging , Lung Transplantation/methods , Lymphoproliferative Disorders/diagnostic imaging , Lymphoproliferative Disorders/etiology , Male , Middle Aged , Pleural Diseases/diagnosis , Pleural Diseases/etiology , Pneumonia, Viral/diagnostic imaging , Pneumonia, Viral/etiology , Pneumothorax/diagnostic imaging , Pneumothorax/etiology , Pulmonary Aspergillosis/diagnostic imaging , Pulmonary Aspergillosis/etiology , Recurrence , Tomography, X-Ray Computed , Vascular Diseases/diagnostic imaging , Vascular Diseases/etiologyABSTRACT
PURPOSE: To validate a computer-aided detection (CAD) tool for the detection of pulmonary arterial filling defects at computed tomographic pulmonary angiography (CTPA) and to assess its benefit for readers of different levels of experience. METHODS: One hundred consecutive CTPA studies were retrospectively evaluated by a chest radiologist for presence of emboli, serving as the reference standard. Subsequently, examinations were analyzed using commercially available second-generation CAD software (ImageChecker CT, version 2.1; R2 Technology, Inc., Sunnyvale, Calif). The staff radiologist assessed all CAD marks and classified them as true positive or false positive (FP), and any unmarked emboli were classified as false negative. Computer-aided detection software was also evaluated on a case basis compared with the reference standard.For the second part of the study, the 100 CTPAs were reviewed by 3 additional readers of different levels of experience, both without and with CAD, and findings correlated with the reference standard. RESULTS: Twenty-one studies (21%) were positive for pulmonary embolism. Of these, 18 were true positive on a case basis, and 3 were false negative. Of the 79 negative studies, 16 were true negative with no CAD marks, and the remaining 63 were FP. On a case basis, CAD sensitivity was 86%, specificity was 20%, negative predictive value was 84%, and positive predictive value (PPV) was 22%.Overall, the CAD software yielded 318 marks, identifying 64 of 93 emboli with an additional 254 FP marks. On a mark basis, sensitivity was 69%, and PPV was 20%.Computer-aided detection did not influence the most experienced reader (a chest fellow). Although CAD improved the subjective confidence of the second-year resident in some cases, it had no influence on overall interpretation or accuracy. Computer-aided detection improved accuracy only for the most inexperienced reader, helping this reader to identify 9 emboli not initially appreciated. CONCLUSIONS: Computer-aided detection specificity and PPV are poor due to expected FP marks, although, often, these can be easily dismissed. However, CAD software may play an important role as a second reader for residents or inexperienced readers.
Subject(s)
Algorithms , Angiography/methods , Pattern Recognition, Automated/methods , Pulmonary Artery/diagnostic imaging , Pulmonary Embolism/diagnostic imaging , Radiographic Image Interpretation, Computer-Assisted/methods , Tomography, X-Ray Computed/methods , Female , Humans , Male , Observer Variation , Radiographic Image Enhancement/methods , Reproducibility of Results , Sensitivity and SpecificitySubject(s)
Antibiotics, Antitubercular/administration & dosage , Clarithromycin/administration & dosage , Ethambutol/administration & dosage , Immunosuppression Therapy/methods , Kidney Transplantation , Mycobacterium Infections, Nontuberculous/drug therapy , Rifampin/administration & dosage , Drug Therapy, Combination , Female , Humans , Kidney Transplantation/methods , Middle Aged , Mycobacterium Infections, Nontuberculous/immunology , Mycobacterium Infections, Nontuberculous/surgery , Recurrence , Treatment OutcomeABSTRACT
Reflux of barium sulfate preparations into the biliary tract is rare, but serious complications have been recorded. To consider the implications of such reflux through enterobiliary stents, the literature was reviewed. A case illustrating such an occurrence is presented. Based upon the limited literature available, barium suspension may be retained in particular circumstances and cause or contribute to stent occlusion.
Subject(s)
Barium Sulfate/adverse effects , Bile Reflux/complications , Cholestasis/prevention & control , Constriction, Pathologic/prevention & control , Stents , Aged, 80 and over , Biliary Tract/physiopathology , Constriction, Pathologic/therapy , Drainage , Equipment Design , Equipment Failure , Humans , Male , Stents/adverse effectsSubject(s)
Asthma/complications , Pulmonary Aspergillosis/complications , Respiratory Insufficiency/etiology , Acute Disease , Adult , Asthma/diagnosis , Bronchoalveolar Lavage Fluid/cytology , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Pulmonary Aspergillosis/diagnosis , Radiography, Thoracic , Respiratory Insufficiency/diagnosis , Severity of Illness IndexABSTRACT
We describe the case of a 13-month-old boy with significant rectal bleeding in which the (99m)Tc pertechnetate scan showed an initial focus of uptake in the left iliac fossa, which faded rapidly at 15 min. At surgery an ulcerated Meckel's diverticulum was found. We therefore highlight the need to consider a Meckel's diverticulum in cases where this atypical scintigraphic appearance is seen.